ReShape Lifesciences
NASDAQ: RSLS
Healthcare
Medical Devices
Rank
#44185
Market Cap
3.00 M
Volume
332,994
Price
6.66
Change (%)
20.05%
Country or region
United States
United States
ReShape Lifesciences Stock Split History Overview
This company has undergone a total of five stock splits throughout its history. Five reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on May 9, 2025 with a ratio of 1-for-25. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
ReShape Lifesciences (NASDAQ: RSLS) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| May 9, 2025 | 1:25 | x0.04 | x4.5977012E-07 | Reverse |
| September 23, 2024 | 1:58 | x0.01724138 | x1.1494253E-05 | Reverse |
| December 23, 2022 | 1:50 | x0.02 | x0.00066666666 | Reverse |
| June 16, 2021 | 1:3 | x0.33333334 | x0.033333335 | Reverse |
| July 25, 2019 | 1:10 | x0.1 | x0.1 | Reverse |
Frequently Asked Questions
If ReShape Lifesciences (stock symbol: NASDAQ: RSLS) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-25) that occurred on May 9, 2025.
ReShape Lifesciences (stock symbol: NASDAQ: RSLS) has undergone a total of five stock splits. The most recent split occurred on May 9, 2025. One share bought prior to the first split on July 25, 2019 would now equal 0.00 shares.
ReShape Lifesciences (stock symbol: NASDAQ: RSLS) has undergone five stock splits in its history. The most recent split, a 1-for-10 split, occurred on May 9, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.